E. Steve Woodle

Papers

Total Citations

H-Index

About

Dr. E. Steve Woodle is a leading figure in transplant surgery and immunology, with a career dedicated to improving outcomes for kidney transplant recipients. His research focuses heavily on the management of antibody-mediated rejection (AMR) and the development of novel antihumoral therapies. A key contribution is his work on the regulatory and clinical barriers to approving new treatments for AMR, as highlighted in a seminal 2011 paper that helped shape the dialogue between the scientific community and the FDA. This work, while cited modestly, reflects his pivotal role in guiding the field toward more effective, evidence-based protocols for desensitization and rejection management. Dr. Woodle has also been instrumental in advancing steroid-free immunosuppression regimens, significantly reducing long-term complications for patients. With a career spanning hundreds of publications and thousands of citations, his impact is felt in both the operating room and the policy arena, making him a trusted voice in transplant medicine. His leadership in clinical trials and consensus conferences has cemented his reputation as a pioneer dedicated to bridging the gap between research and real-world patient care.